methadone, buprenorphine, heroin, morphine or opium. This analysis also excludes admissions for shelter/detoxification services. Why Indicator is Important: The number of substance abuse treatment admissions is bound by both the need and the capacity for treatment. Therefore, treatment admission data do not provide a good indication of substance use, abuse or dependence. They do, however, provide an indication of service usage and the impact of substance use on the behavioral healthcare system. Data Source(s): TDS, 2007-2011 Summary: Synthetic opiates are the second most frequent substance for which treatment is sought in Maine. After a three year period (2008-2010) of stability, the number of treatment admissions related to synthetic opiates appears to have decreased slightly. Figure 80. Number of treatment admissions where synthetic opioids was the primary, secondary, or tertiary substance: 2007-2011 Source: TDS, 2007-2011 In 2011, there were 3,630 primary treatment admissions involving synthetic opiates. The number of admissions where synthetic opiates are listed as a secondary substance has recently decreased, after a steady rise from 2007 to 2010. Figure 81. Percent of total treatment admissions where synthetic opioids was the primary, secondary, or tertiary substance: 2007-2011 Source: TDS, 2007-2011 In 2011, synthetic opiates were the primary substance for which treatment was sought in 32 percent of all treatment admissions and were listed the secondary substance in 28 percent of admissions that listed a second substance. Marijuana Indicator Description: TREATMENT ADMISSIONS RELATED TO MARIJUANA. This measure reflects substance abuse treatment admissions in which marijuana is listed as the primary, secondary, or tertiary substance for which treatment is sought. This analysis excludes admissions for shelter/detoxification services.
methadone, buprenorphine, heroin, morphine or opium. This analysis also excludes admissions for shelter/detoxification services. Why Indicator is Important: The number of substance abuse treatment admissions is bound by both the need and the capacity for treatment. Therefore, treatment admission data do not provide a good indication of substance use, abuse or dependence. They do, however, provide an indication of service usage and the impact of substance use on the behavioral healthcare system. Data Source(s): TDS, 2007-2011 Summary: Synthetic opiates are the second most frequent substance for which treatment is sought in Maine. After a three year period (2008-2010) of stability, the number of treatment admissions related to synthetic opiates appears to have decreased slightly. Figure 80. Number of treatment admissions where synthetic opioids was the primary, secondary, or tertiary substance: 2007-2011 Source: TDS, 2007-2011 In 2011, there were 3,630 primary treatment admissions involving synthetic opiates. The number of admissions where synthetic opiates are listed as a secondary substance has recently decreased, after a steady rise from 2007 to 2010. Figure 81. Percent of total treatment admissions where synthetic opioids was the primary, secondary, or tertiary substance: 2007-2011 Source: TDS, 2007-2011 In 2011, synthetic opiates were the primary substance for which treatment was sought in 32 percent of all treatment admissions and were listed the secondary substance in 28 percent of admissions that listed a second substance. Marijuana Indicator Description: TREATMENT ADMISSIONS RELATED TO MARIJUANA. This measure reflects substance abuse treatment admissions in which marijuana is listed as the primary, secondary, or tertiary substance for which treatment is sought. This analysis excludes admissions for shelter/detoxification services.
EpiProfile2012.docx